Page 317 - Syndipharma
P. 317
Type Product Dosage form Strength Indication Status
Rheumatoid Arthritis
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
RHOFANIB ® Active market
Oral product F.C TABLET 10MG Psoriasis authorization
(TOFACITINIB)
Ulcerative colitis
0.5MG, Prevention of organ rejection
SUPROTAC ® in heart, kidney and liver trans-
Oral product Oral Hard Gela- 1MG, plantation Active market
authorization
tin Capsule
(TACROLIMUS)
5MG
316